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Abstract: Pan-azole resistant isolates are found in clinical and environmental Aspergillus fumiga-
tus (Af ) populations. Azole resistance can evolve in both settings, with Af directly targeted by
antifungals in patients and, in the environment, Af unintendedly exposed to fungicides used for
material preservation and plant disease control. Resistance to non-azole fungicides, including methyl
benzimidazole carbamates (MBCs), quinone outside inhibitors (QoIs) and succinate dehydrogenase
inhibitors (SDHIs), has recently been reported. These fungicide groups are not used in medicine but
can play an important role in the further spread of pan-azole resistant genotypes. We investigated
the multi-fungicide resistance status and the genetic diversity of Af populations sampled from tulip
field soils, tulip peel waste and flower compost heaps using fungicide sensitivity testing and a range
of genotyping tools, including STRAf typing and sequencing of fungicide resistant alleles. Two major
clones were present in the tulip bulb population. Comparisons with clinical isolates and literature
data revealed that several common clonal lineages of TR34/L98H and TR46/Y121F/T289A strains
that have expanded successfully in the environment have also acquired resistance to MBC, QoI
and/or SDHI fungicides. Strains carrying multiple fungicide resistant alleles have a competitive
advantage in environments where residues of multiple fungicides belonging to different modes of
action are present.
Keywords: fungicide resistance; azole fungicides; fungicide target proteins; CYP51A; aspergillosis;
Aspergillus fumigatus; clonal lineages
1. Introduction
Airborne Aspergillus fumigatus (Af ) spores can, after inhalation, cause disease in
animals and humans ranging from allergic conditions and chronic lung infection to acute
invasive aspergillosis (IA). Patients with a weakened immune system are most at risk for IA,
and successful therapy depends on early diagnosis and the effective use of antifungals. Due
to their efficacy and low toxicity, orally administered azoles have been the drugs of choice,
followed by intravenous applications of amphotericin B and echinocandins. However,
azole resistance has evolved in Af and is becoming more common in both the clinical
setting and the wider environment since the late 1990s [1–3]. Further spread of resistance
will have a significant clinical impact as higher mortality rates have already been recorded
for patients with voriconazole-resistant IA in comparison with voriconazole-susceptible
infection [4].
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Azoles inhibit the enzyme sterol 14α-demethylase (CYP51), a key step in the synthesis
of sterols essential for the integrity of cell membranes. Although different azole resistance
mechanisms are known [5–7], azole resistance in clinical and environmental Af isolates is
mainly associated with alterations in the regulatory and/or coding region of the CYP51A
paralogue [8,9]. Azole resistance developed during azole therapy is often associated
with single mutations, including G54A/E/RV/W, P216L, M220I/K/L/R/T/V and G448S,
conferring different levels of resistance to different azoles. Most highly multi-azole resistant
strains found both in clinical settings and the environment belonged to three unique,
more complex genotypes—TR34/L98H, TR34/L98H/S297T/F495I and TR46/Y121F/T289A.
These CYP51A variants are based on a combination of promoter tandem repeat (TR)
insert of 34 or 46 bp with mutations resulting in amino acid substitutions L98H, Y121F,
S297T, T289A and F495I. Isolates carrying TR34/L98H have been found in Europe since
1998 [10]. TR34/L98H/S297T/F495I, first detected in the Netherlands in 1998 [2], is often
found in Asia [11,12], whereas the first TR46/Y121F/T289A isolate was reported from
North America in 2008 [13]. More complex CYP51A variants have recently emerged,
including TR34/L98H/T289A/I364V/G448S, TR46/Y121F/T289A/S363P/I364V/G448S
and different TR46 variants (TR462, TR463 and TR464) in combination with Y121F, M172V,
T289A and G448S [14–17].
Recent studies have shown that several TR34- and TR46-based CYP51A variants have
evolved resistance to non-azole fungicides belonging to different modes of action that
are not used in medicine [17–19]. These fungicides, methyl benzimidazole carbamates
(MBC), quinone outside inhibitors (QoI) and succinate dehydrogenase inhibitors (SDHI),
targeting β-tubulin (cytoskeleton), cytochrome b (respiration) and succinate dehydrogenase
(respiration), respectively, are commonly used to control plant diseases and resistance
development in Af is an unintended side effect as agronomically used azole fungicides are
not directly targeted against Af. Although TR34/TR46-based CYP51A have been associated
with the environmental route of resistance development rather than the patient route, the
origin of these strains without additional CYP51A mutations remains unclear and an initial
selection in the clinical setting with subsequent spread through aerosols into the wider
environment cannot be excluded [20,21]. However, fungicide resistance can evolve in
the environment and measures should be taken to prevent further spread to retain the
effectiveness of the azole class for both environmental and medical applications [22].
Research is ongoing to determine the hotspots for resistance development and spread.
Tulip bulbs have previously been identified as a vehicle for international spread of azole
resistant Af isolates [23,24]. Decaying flower bulb waste from farms, industrial wood-chip
waste, and industrial green-waste storage, able to support the growth and reproduction of
Af in the presence of fungicides, have already been identified as hotspots [25]. A better
understanding on the emergence and spatiotemporal spread of different fungicide resistant
alleles can improve our understanding on hotspots for fungicide resistance development
and aid development of measures to reduce exposure risk.
The aim of this study was to investigate the resistance status of Af populations sampled
from tulip field soils, tulip bulbs, tulip peel waste piles and flower compost heaps to azole,
MBC, QoI and SDHI fungicides. A panel of clinical isolates and a set of environmental
isolates, that were characterized in a previous study [17], were also included to compare the
fungicide sensitivity phenotypes and genotypes. Sequencing of genes encoding fungicide
target proteins, cell surface protein (CSP) and mating type, as well as microsatellite typing
based on short tandem repeats (STRAf ) was carried out for all strains to identify genetical
relatedness and to check for clonal expansion [26,27]. The spread of clonal lineages in both
the environment and the clinical setting is further discussed using data that can be found
in the literature or the available AfumID database [28].
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2. Materials and Methods
2.1. Sampling and Strain Isolation
In total, 32 samples, ranging from tulip field soils (soil not in close contact with bulbs
was sampled), flower bulbs, tulip peel waste heaps (decaying material) and flower waste
compost sites were studied (Table 1). Soils from six tulip fields at five locations were
sampled to a depth of 8 cm at three sampling points, separated five meters apart during
summer in 2016.
Table 1. Collected samples with their locations.




Soil tulip field 1 Biddinghuizen, NL (2016) 0/30
Soil tulip field 2 Dronten, NL (2016) 1/30
Soil tulip field 3 Venhuizen, NL (2016) 1/30
Soil tulip field 4 Westwoud, NL (2016) 0/30
Soil tulip field 5 Westwoud, NL (2016) 5/30
Soil tulip field 6 Zyperdijk, NL (2016) 3/30
Bulbs 1 Tulipa ‘Stresa’ Noordwijkerhout, NL (2015) 4/10
Bulbs 2 Tulipa ‘Apeldoorn Yellow’ Vaassen, NL (2015) 4/10
Bulbs 3 Tulipa greigii ‘Roodkapje’ Vaassen, NL (2015) 4/10
Bulbs 4 Tulipa ‘Praestans Shogun’ Vaassen, NL (2015) 3/10
Bulbs 5 Tulipa ‘Claudia’ Noordwijkerhout, NL (2015) 6/10
Bulbs 6 Tulipa ‘Triumph Hotpants’ Millbrook, UK (2015) 1/8
Bulbs 7 Tulipa ‘Mickey Mouse’ Canterbury, UK (2015) 1/10
Bulbs 8 Tulipa ‘Gavota’ Wickford, UK (2015) 0/10
Bulbs 9 Tulipa ‘Guiseppi Verdi’ Horsham, UK (2015) 0/10
Bulbs 10 Tulipa ‘White Marvel’ Preston, UK (2015) 1/10
Bulbs 11 Tulipa ‘Red Impression’ Hillegom, NL (2015) 1/10
Bulbs 12 Tulipa ‘Negrita’ Vaassen, NL (2017) 0/10
Bulbs 13 Tulipa ‘Rembrand’ Vaassen, NL (2017) 0/10
Bulbs 14 Narcissus ‘Pink Pride’ Vaassen, NL (2017) 0/10
Bulbs 15 Narcissus ‘Jetfire’ Vaassen, NL (2017) 0/10
Bulbs 16 Narcissus mix Hillegom, NL (2017) 0/10
Bulb peel waste heap tulip grower 1 NL (2018) 6/11
Bulb peel waste heap tulip grower 2 NL (2018) 1/1
Bulb peel waste heap tulip grower 3 NL (2018) 1/2
Bulb peel waste heap tulip grower 4 NL (2018) 3/4
Bulb peel waste heap tulip grower 5 NL (2018) 11/19
Bulb peel waste heap tulip grower 6 NL (2018) 1/5
Compost heap tulip grower A NL (2018) 8/8
Compost heap tulip grower B NL (2018) 1/1
Compost heap tulip grower C NL (2018) 10/10
1 Isolates were obtained from colonies growing on Sabouraud Dextrose agar plates without fungicides with
exception of the compost heap isolates that were picked from plates amended with 5 µg/mL tebuconazole.
2 Azole resistant isolates have at least two raised MIC values for either voriconazole (>1.0 µg/mL), imazalil
(>2.0 µg/mL) and/or tebuconazole (>4.0 µg/mL).
Materials from tulip peel waste heaps and compost sites were sampled and sent in by
commercial tulip growers during August 2018. For both soil, bulb peel waste heap and
compost samples, 2 g aliquots of material were added to 8 mL of phosphate buffered saline
amended with 0.1% (v/v) Tween 20 (PBST) and Af strains isolated as described in our
previous study [17]. Tulip and daffodil bulbs were purchased directly from garden centers
or ordered on-line from nurseries in the autumn during 2016–2018. The outer skin of ten
bulbs per sample was peeled off, pooled, and further processed using 25 mL of PBST. To
grow and isolate Af colonies aliquots of the buffer extracts were plated out on untreated, or
azole fungicide (5 µg/mL tebuconazole) amended Sabouraud dextrose (SD) agar (Oxoid
Ltd., Basingstoke, UK) containing penicillin (100 U/mL) and streptomycin (100 µg/mL)
and incubated for 2 days at 48 ◦C.
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2.2. Panel of Clinical Isolates
A study of a panel of 20 Af clinical strains, which included 18 azole-insensitive and
two reference strains (AF65 (National Collection of Pathogenic Fungi (NCPF) 7097)) and
AF293 (NCPF 77367)), all isolated before 2018, was also caried out to allow comparisons
of the fungicide sensitivity pheno- and genotypes found in the clinical setting and in the
environment. The isolates originated from Belgium (CYP_15_2, 15_7, 15_38, 15_46, 15_63
and 15_80), Germany (Asp 164, 168, 251 and 267), Japan (OKH50 (2016)), Taiwan (D007),
the Netherlands (ARAF013, ARAF017, V093-26 (2010) and V094-54 (2009) and the UK
(AF65 (1997), AF293 (1993), CXH_06 and 07).
2.3. Fungicide Sensitivity Testing
After subculturing single colonies in tissue culture flasks with 12 mL SD agar for
seven days at 37 ◦C, spores were harvested through shaking with 5 mm glass beads after
addition of 3 mL of saline. Spore suspensions containing approximately 106 spores/mL
in sterile distilled water were used in the microprocessor controlled Autoplate Spiral
Plating System AP5000 (Advanced Instruments, Norwood, MA, USA) according to the
manufacturer’s instructions as described previously [17]. Depending on the molecular
weight of the compounds, an up to a 200-fold fungicide dilution gradient on SD agar was
achieved using 15 cm plates. The concentration ranges (µg/mL) for the different fungicides
were: boscalid (0.1–18.469), carbendazim (0.1–11.464), imazalil (0.25–43.153), itraconazole
(0.025–6.113 or 0.1–22.324), posaconazole (0.005–1.0) (pyraclostrobin (0.1–20.120), tebu-
conazole (0.1–17.349), terbinafine (0.01–1.7) and voriconazole (0.1–19.120). The different
concentration ranges were chosen to distinguish sensitive wild-type (wt) isolates without
known resistance mechanisms from those of insensitive isolates harboring resistance mech-
anism(s) in a single assay. Isolates were streaked on the spiral SD agar plates (eight per
plate) from the outside to the center using cotton swaps and incubated at 37 ◦C in the dark.
After 24 h incubation, the fungal growth of each isolate on the spiral plate was visually
assessed and MIC values determined using the Spiral Gradient Endpoint (SGE) software.
2.4. DNA Extractions
After harvesting spores from one-week cultures in tissue culture flasks, 1.5 mL of
spore suspensions was transferred into a 2 mL tube and centrifuged for 2 min at 13,200 rpm.
After removing the supernatant, DNA was extracted according to the MasterPure Yeast
DNA Purification kit (Lucigen Corporation, Madison, WI, USA) with the inclusion of an
extra bead-beating step, which involved the addition of glass beads (0.425–0.600 mm) and
the use of the Genie 2 Vortex (Scientific Industries, Bohemia, NY, USA) at full power for
2 min. This step was carried out after the lysis step just before adding the MPC Protein
Precipitation Reagent.
2.5. PCR Amplification and Sequencing of Fungicide Resistant Alleles
Whole or partial fungicide target genes (β-tubulin, cytochrome b and succinate hy-
drogenase subunit B), covering all regions where mutations affecting inhibitor binding
have been reported for fungi, were amplified with PCR, sequenced, and analyzed using
Geneious software version 10.0 (Biomatters, Auckland, New Zealand) according to the
previously established protocols [17].
2.6. Cell Surface Protein Typing
The cell surface protein (CSP) (XM_749624.1) encoding gene of Af was also partially
sequenced from selected strains [29]. CSP typing of strains, including CSP t02* or t02B [17],
was carried out according to the established nomenclature [26], which is based on the
tandem repeat region, in which up to ten different 12-bp repeat sequences have been
found in different copy numbers, and the flanking regions. After manual alignment of
sequences, a phylogenetic tree for the different CSP sequences encountered in this study
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was constructed using the Geneious Tree Builder software (Biomatters, Auckland, New
Zealand) based on the Tamura-Nei distance model and the Neighbor-Joining method.
2.7. Microsatellite Typing Based on Short Tandem Repeats in A. fumigatus (STRAf)
In total, 128 Af isolates with different levels of azole sensitivity from this study and our
previous studies on environmental and reference isolates were further characterized using
microsatellite genotyping based on a panel of nine short tandem repeat markers (STRAf
2A, 2B, 2C, 3A, 3B, 3C, 4A, 4B and 4C) according to the method previously described
and validated [27,30]. GenAlEx v.6.503 software was used to identify distinct multi-locus
genotypes (MLGs), where a single difference in an allele size was considered enough to
discriminate a unique MLG [31]. To visualize the phylogenetic relationships among MLGs,
a minimum spanning network (MSN) was generated using the R package poppr v.2.8.3 [32],
which is based on Bruvo’s distance [33].
3. Results
3.1. Isolation and Fungicide Sensitivity Testing of A. fumigatus Isolates from Tulip Field Soils
In total, 180 isolates were isolated from soils sampled from six fields at five different
locations (Table 1). Figures 1 and 2 show the sensitivity profiles for the overall population
to eight different fungicides.
The frequency of pan-azole resistant isolates within this population varied between
0% and 16.7% per field (n = 30) with an average overall frequency of 5.6% (10 out of
180) (Table 1). Amongst the 10 pan-azole resistant isolates, three isolates from these
(STNL5-B7, STNL5-C1 and STNL5-C8), all isolated from tulip field 5 (Table 1), carried
TR46/Y121F/T289A and showed high levels of insensitivity to all azoles, itraconazole
(>22.324 µg/mL), voriconazole (>19.120 µg/mL), posaconazole (>0.200 µg/mL), imazalil
(>15.0 µg/mL) and tebuconazole (>17.349 µg/mL), carbendazim (>11.464 µg/mL) and
pyraclostrobin (>20.120 µg/mL). Six out of seven isolates, showing lower levels of insensi-
tivity to most of the azoles tested, carried TR34/L98H. Four of these (STNL2-B8, STNL5-B6,
STNL6-A3 and STNL6-B2) were sensitive to both carbendazim and pyraclostrobin (MIC
values below 3.0 µg/mL), while STNL3-C8 was highly insensitive to pyraclostrobin but not
carbendazim, and STNL6-B1 highly insensitive to both carbendazim and pyraclostrobin.
The remaining isolate, STNL5-C5, with low levels of insensitivity to multiple azoles carried
TR34/L98H/S297T/F495I and was also insensitive to carbendazim.
Only one azole sensitive strain, STNL1-A8 with wild-type CYP51A, was resistant to
carbendazim. Several strains showing low levels of insensitivity to tebuconazole, in partic-
ular, carried F46Y/M172V/E427K. Amongst these strains, STNL2-C9 showed a raised MIC
value of 6.017 µg/mL to pyraclostrobin. As expected, only small differences in sensitivity
to terbinafine, a squalene epoxidase inhibitor, were measured for all isolates and this was
not linked to a CYP51A variant. Of the medical azoles tested, posaconazole was most
effective with the majority of isolates displaying MICs between 0.007 and 0.046 µg/mL,
followed by voriconazole (most strains in MIC range 0.100 to 0.657 µg/mL), imazalil (most
strains in MIC range 0.250 to 1.643 µg/mL), tebuconazole (most strains in MIC range
0.110 to 1.710 µg/mL) and itraconazole (most strains in MIC range 0.403 to 1.774 µg/mL),
respectively (Figure 1). A wide range of sensitivities were measured for itraconazole with a
large fraction of isolates (n = 33), the majority carrying wild-type CYP51A alleles, having
MIC values exceeding 10.000 µg/mL.
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and carbendazim out of range values spiral plating MIC values were displayed as the log values of 19.120, 17.349 and
11.464 µg/mL, respectively.
3.2. Isolation and Fungicide Sensitivity Testing of A. fumigatus Isolates from Flower Bulbs, Tulip
Peel Waste Heaps and Compost
In total, 200 strains were isolated from tulip bulbs (n = 128), daffodil bulbs (n = 30) and
tulip peel waste (n = 42) on SD agar without addition of tebuconazole and 19 strains from
compost (n = 19) on tebuconazole-amended SD agar (Table 1). Eight additional strains were
also isolated from three different tulip peel waste samples using tebuconazole-amended SD
agar. The results of the fungicide sensitivity tests for the four largest populations together
with the tulip soil population are displayed in Figure 2, while test results for a selection of
individual strains are shown in Table 2.
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Table 2. Sensitivity of environmental Aspergillus fumigatus isolates to a panel of fungicides belonging to different modes of
action and their further characterization using CSP, mating type and CYP51A variant analysis. Isolates ranked according to
voriconazole sensitivity (low to high MIC values in µg/mL).
Isolate CYP51A VRC IMA TEB CAR PYR BOS CSP MatingType
STNL1-A8 WT 0.292 0.714 0.814 >11.464 1.110 - t04A MAT1-1
T8-2 WT 0.471 0.803 0.643 1.169 0.872 0.253 t11 MAT1-1
STNL5-C5 TR34/L98H/S297T/F495I 0.531 8.367 4.227 >11.464 0.685 0.199 t02 MAT1-2
T6-3 TR34/L98H 0.675 5.236 >17.349 2.013 0.477 - t11 MAT1-1
STNL2-C9 F46Y/M172V/E427K 0.760 1.443 2.970 0.843 6.017 - t02B MAT1-1
STNL3-C8 TR34/L98H 0.857 1.283 4.227 1.303 >20.120 - t04B MAT1-1
TP UT1A-2 TR34/L98H 0.857 8.367 5.348 >11.464 >20.120 0.253 t02 MAT1-2
STNL6-B2 TR34/L98H 1.381 2.592 4.227 1.169 0.538 0.157 - MAT1-1
STNL6-A3 TR34/L98H 1.381 3.277 6.768 1.303 0.538 0.199 t01 MAT1-2
T3-6 TR34/L98H 1.381 6.619 >17.349 2.013 1.110 0.253 t11 MAT1-1
TP UT1B-1 TR34/L98H 1.754 6.619 >17.349 >11.464 >20.120 0.517 t11 MAT1-1
TP UT5C-5 TR34/L98H 1.754 6.619 4.227 0.679 >20.12 0.224 t02 MAT1-2
STNL2-B8 TR34/L98H 1.754 10.577 4.227 2.013 0.294 0.321 t04B MAT1-1
STNL5-B6 TR34/L98H 2.227 1.622 3.341 1.619 0.872 0.321 t11 MAT1-2
T2-1 TR34/L98H 2.227 4.142 >17.349 1.619 1.110 0.321 t11 MAT1-1
STNL6-B1 TR34/L98H 4.047 5.887 >17.349 >11.464 >20.120 >18.469 t01 MAT1-2
T11-8 TR34/L98H 5.139 10.577 >17.349 >11.464 >20.120 0.517 t02 MAT1-1
STNL5-B7 TR46/Y121F/T289A >19.120 16.901 >17.349 >11.464 >20.120 0.157 t02 MAT1-1
T7-9 TR46/Y121F/T289A >19.120 24.020 >17.349 >11.464 >20.120 - t01 MAT1-1
TP UT4A-1 TR46/Y121F/T289A >19.120 34.138 >17.349 >11.464 >20.120 0.407 t01 -
STNL5-C1 TR46/Y121F/T289A >19.120 >43.153 >17.349 >11.464 >20.120 0.177 t06A MAT1-1
STNL5-C8 TR46/Y121F/T289A >19.120 >43.153 >17.349 >11.464 >20.120 0.199 - MAT1-2
T3-5 TR46/Y121F/T289A >19.120 >43.153 >17.349 >11.464 >20.120 - t01 MAT1-1
T4-9 TR46/Y121F/T289A >19.120 >43.153 >17.349 >11.464 >20.120 - t01 MAT1-1
T4-10 TR46/Y121F/T289A >19.120 >43.153 >17.349 >11.464 >20.120 - t01 MAT1-1
T5-1 TR46/Y121F/T289A >19.120 >43.153 >17.349 >11.464 >20.120 0.285 t01 MAT1-1
T5-2 TR46/Y121F/T289A >19.120 >43.153 >17.349 >11.464 >20.120 - t01 MAT1-1
T5-5 TR46/Y121F/T289A >19.120 >43.153 >17.349 >11.464 >20.120 - t01 MAT1-1
TP TEB5C-2 TR34/L98H/T289A/I364V/G448S >19.120 >43.153 >17.349 >11.464 >20.120 0.321 t02 MAT1-2
TC TEB6B-1 TR34/L98H/T289A/I364V/G448S >19.120 >43.153 >17.349 >11.464 >20.120 >18.469 t02 MAT1-2
VRC (voriconazole), IMA (imazalil) and TEB (tebuconazole) are azoles, inhibiting 14α-demethylase (sterol biosynthesis); CAR (carbendazim)
is a MBC fungicide, inhibiting β-tubulin assembly (cytoskeleton); PYR (pyraclostrobin) is a QoI fungicide, inhibiting respiration (complex
III); BOS (boscalid) is a SDHI fungicide, inhibiting respiration (complex II); -, not determined.
As expected, 19 compost isolates (Table 1), all isolated from tebuconazole-amended
SD agar, showed high levels of insensitivity to all azoles tested, with 18, 17 and 14 of these
also having MIC values exceeding 17.349, 19.120 and 43.153 µg/mL, for tebuconazole,
voriconazole and imazalil, respectively (Figure 2). All 19 isolates were also highly insensi-
tive to both carbendazim and pyraclostrobin having MIC values greater than 11.464 and
20.120 µg/mL, respectively.
Tulip peel waste heaps also contained high frequencies of multi-fungicide insensitive
isolates, with 23 out of 42 strains tested insensitive to multiple azoles and pyraclostrobin,
respectively (Figure 2). Of these, 22 were also highly insensitive to carbendazim. Six out
of 23 were highly insensitive to voriconazole, tebuconazole and imazalil showing MICs
greater than 10 ppm (including TP UT4A-1 and TP UT4B-2), while the remaining isolates
(including TP UT1B-1, TP UT1A-2 and TP UT5C-5), showed raised levels of insensitivity to
one or more azoles. All 19 isolates that were sensitive to pyraclostrobin were also sensitive
to all azoles tested with MICs lower than 1.0, 2.0 and 4.0 µg/mL for voriconazole, imazalil
and tebuconazole, respectively. All eight strains isolated from tebuconazole-amended SD
agar were insensitive to both carbendazim and pyraclostrobin and showed high levels of
insensitivity to multiple azoles (including TP TEB5C-5).
The frequency of multi-fungicide resistant isolates was much lower for the sampled
population from tulip bulbs (Figure 2). Only eight out of 128 isolates were highly insensitive
to carbendazim, of which seven (T3-5, T4-9, T4-10, T5-1, T5-2, T5-5 and T7-9) were also
highly insensitive to voriconazole, tebuconazole and imazalil, showing MICs greater
than 10 µg/mL. Reduced sensitivity to two or more azoles (MICs exceeding 1.0, 2.0 and
4.0 µg/mL for voriconazole, imazalil and tebuconazole, respectively) were measured for
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the other carbendazim insensitive isolate (T11-8) and 17 additional isolates (including T2-1,
T3-6 and T6-3). None of the strains isolated from daffodil bulbs showed any levels of
insensitivity to carbendazim, voriconazole and tebuconazole while only one isolate tested
positive for imazalil, with a MIC of 2.051 µg/mL just above the discriminatory dose of
2.0 µg/mL.
3.3. Azole Resistance Phenotype-to-Genotype Relationship, Cell Surface Protein and Mating
Typing of A. fumigatus Isolates from the Environment with a Focus on Tulip Cultivation
A selection of 30 environmental Af isolates with different levels of insensitivity to
azoles, carbendazim and/or pyraclostrobin were further tested for sensitivity to boscalid
and were further characterized by determination of CSP, mating type and fungicide resis-
tant alleles (Table 2).
Isolates carrying TR46/Y121F/T289A, frequently detected in this study, and TR34/
L98H/T289A/I364V/G448S, only detected in two strains isolated from tulip peel waste (TP
TEB5C-5) and tulip compost (TC TEB6B-1) on tebuconazole-amended SD agar were highly
insensitive to all azoles tested, with high MIC values greater than or equal to 19.120, 17.349
and 16.901 µg/mL measured for voriconazole, tebuconazole and imazalil, respectively
(Table 2). Isolates carrying TR34/L98H showed lower levels of azole insensitivity to
voriconazole and imazalil, but six out of 13 were also highly insensitive to tebuconazole
(MIC values > 17.349 µg/mL). STNL5-C5, carrying TR34/L98H/S297T/F495I showed a
low level of insensitivity to voriconazole and tebuconazole, but its insensitivity to imazalil
(MIC value of 8.367 µg/mL) was high in comparison to most TR34/L98H isolates. Isolate
STNL2-C9, carrying F46Y/M172V/E427K, showed only slightly raised MIC values for
voriconazole, imazalil and tebuconazole in comparison with wild-type CYP51A strains.
All TR46/Y121F/T289A and TR34/L98H/T289A/I364V/G448S isolates, as well as
four out of 13 TR34/L98H isolates tested, were also insensitive to both carbendazim (MIC
values > 11.464 µg/mL) and pyraclostrobin (MIC values > 20.120 µg/mL). Insensitivity to
carbendazim but not to pyraclostrobin was also measured for STNL1-A8 and STNL5-C5,
carrying wild-type CYP51A and TR34/L98H/S297T/F495I, respectively. Sensitivity to car-
bendazim and a moderate level of pyraclostrobin insensitivity (MIC value of 6.017 µg/mL)
was measured for isolate STNL2-C9, carrying F46Y/M172V/E427K. High levels of insen-
sitivity to pyraclostrobin but not to carbendazim were measured for TR34/L98H isolates
STNL3-C8 and TP UT5C-5. Resistance to boscalid (MIC values > 18.469 µg/mL) was
found in two isolates with high insensitivity to the different azoles, carbendazim and pyra-
clostrobin, being STNL6-B1 and TC TEB6B-1 carrying TR34/L98H and TR34/L98H/T289A/
I364V/G448S, respectively.
β-tubulin sequence analysis revealed that insensitivity to carbendazim was conferred
in all environmental isolates by the amino acid substitution F200Y (codon change TTC to
TAC). Isolate STNL5-C5, carrying TR34/L98H/S297T/F495I, showed a double nucleotide
change resulting in F200Y (TTC to TAT). High levels of pyraclostrobin insensitivity (MIC val-
ues > 20.120 µg/mL) were associated with the cytochrome b alteration G143A (GGT to GCT),
whereas the lower level of insensitivity to pyraclostrobin (MIC value of 6.017 µg/mL) in
isolate STNL2-C9 was linked to cytochrome b F129L (TTC to TTA). Insensitivity to boscalid
was conferred by SdhB alteration H270Y (CAC to TAC) in STNL6-B1 and TC TEB6B-1.
Multiple CSP and mating types were found in both TR46/Y121F/T289A (CSP t01, t02
and t06A) and TR34/L98H isolates (CSP t01, t02, t04B and t11). CSP t02 and t02B were
detected in STNL5-C5 (TR34/L98H/S297T/F495I) and STNL2-C9 (F46Y/M172V/E427K),
respectively, whereas both TR34/L98H/T289A/I364V/G448S isolates carried CSP t02
and MAT1-2.
3.4. Azole Resistance Phenotype-to-Genotype Relationship, Cell Surface Protein and Mating
Typing of A. fumigatus Isolates from the Clinical Setting
Results for the panel of 20 clinical Af isolates, including AF65 and AF293 as reference
isolates, are presented in Table 3. The order of the voriconazole sensitivity mirrored the
results for the environmental isoles with the reference isolates AF65 (wild-type CYP51A)
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and AF293 (F46Y/M172V/N284T/D255E/E427K) most sensitive, followed by isolates car-
rying TR34/L98H/S297T/F495I, TR34/L98H and TR46/Y121F/T289A, respectively. With
regard to imazalil, four isolates with TR34/L98H/S297T/F495I showed a higher level
of insensitivity, approximately three-fold, than most TR34/L98H isolates. In compari-
son with the MIC value of the wild-type isolate AF65, the average MIC value of the
TR34/L98H/S297T/F495I isolates was approximately 15-fold higher (Resistance Factor
(RF) of 15). TR46/Y121F/T289A were most insensitive, with RF > 25. TR34/L98H and
TR34/L98H/S297T/F495I isolates showed different levels of insensitivity to tebuconazole
(MIC values ranging from 3.341 to >17.349 µg/mL) with several strains also highly insensi-
tive to carbendazim (MIC values > 11.464 µg/mL). Two TR34/L98H isolates, ARAF017 and
CYP_15_46, were insensitive to fungicides belonging to all four different modes of action
(azoles, MBC and QoI and SDHI fungicides). All six TR46/Y121F/T289A isolates showed
high levels of insensitivity to tebuconazole and were also higly insensitive to both carben-
dazim (MIC values > 11.464 µg/mL) and pyraclostrobin (MIC values > 20.120 µg/mL).
One isolate, CYP_15_46, was also insensitive to boscalid (MIC value > 18.469 µg/mL).
Table 3. Sensitivity of clinical Aspergillus fumigatus isolates to a panel of fungicides belonging to different modes of action
and their further characterization using CSP, mating type and CYP51A variant analysis. Isolates ranked according to
voriconazole sensitivity (low to high MIC values in µg/mL).
Isolate CYP51A VOR IMA TEB CAR PYR BOS CSP MatingType
AF65 WT 0.329 1.141 0.814 1.619 1.413 0.157 t02 MAT1-2
AF293 F46Y/M172V/N284T/D255E/E427K 0.531 2.915 1.649 1.303 0.538 - t06A MAT1-2
ARAF013 TR34/L98H/S297T/F495I 0.760 13.370 4.227 >11.464 0.332 0.253 t11 MAT1-2
Asp 251 TR34/L98H/S297T/F495I 1.088 19.002 5.348 >11.464 1.413 0.157 t02 MAT1-1
CYP_15_63 TR34/L98H/S297T/F495I 1.088 13.370 6.768 >11.464 1.110 1.702 t01 MAT1-1
D007 TR34/L98H/S297T/F495I 1.088 15.032 3.341 0.843 0.100 0.285 t04A MAT1-1
CXH_07 TR34/L98H 1.381 5.887 6.768 1.303 0.332 0.199 t04A MAT1-1
Asp 267 TR34/L98H 1.381 4.142 4.227 1.619 0.161 0.157 t11 MAT1-2
CXH_06 TR34/L98H 1.557 5.236 8.563 1.303 0.423 0.321 t04B MAT1-2
Asp 164 TR34/L98H 1.976 6.619 6.768 1.619 1.110 0.224 t11 MAT1-2
Asp 168 TR34/L98H 1.976 5.236 8.563 2.013 0.607 0.199 t04B MAT1-2
OKH50 TR34/L98H 2.227 4.142 5.348 0.757 0.332 0.407 t02 MAT1-2
ARAF017 TR34/L98H 4.560 13.370 >17.349 >11.464 >20.12 >18.469 t04A MAT1-2
CYP_15_46 TR34/L98H 5.791 8.367 13.711 >11.464 >20.12 >18.469 t02 MAT1-1
CYP_15_80 TR46/Y121F/T289A 9.338 >43.153 8.563 >11.464 >20.12 0.199 t02 MAT1-1
CYP_15_2 TR46/Y121F/T289A >19.12 >43.153 13.711 >11.464 >20.12 0.253 t01 MAT1-2
CYP_15_7 TR46/Y121F/T289A >19.12 >43.153 >17.349 >11.464 >20.12 0.253 t01 MAT1-2
CYP_15_38 TR46/Y121F/T289A >19.12 >43.153 >17.349 >11.464 >20.12 >18.469 t09 MAT1-2
V093-26 TR46/Y121F/T289A >19.12 27.006 8.563 >11.464 >20.12 0.517 t01 MAT1-2
V094-54 TR46/Y121F/T289A >19.12 >43.153 >17.349 >11.464 >20.12 0.285 t01 MAT1-2
VRC (voriconazole), IMA (imazalil) and TEB (tebuconazole) are azoles, inhibiting 14α-demethylase (sterol biosynthesis); CAR (carbendazim)
is a MBC fungicide, inhibiting β-tubulin assembly (cytoskeleton); PYR (pyraclostrobin) is a QoI fungicide, inhibiting respiration (complex
III); BOS (boscalid) is a SDHI fungicide, inhibiting respiration (complex II); -, not determined.
β-tubulin sequence analysis revealed that insensitivity to carbendazim was conferred
in all but one isolate by the amino acid substitution F200Y (codon change TTC to TAC). Car-
bendazim insensitivity in isolate CYP_15_46 was conferred by the beta-tubulin alteration
E198A (GAG to GCG). Like the enviromental strains, mutations resulting in cytochrome b
G143A (GGT to GCT) and SdhB H270Y (CAC to TAC) were found in all isolates insensitive
to carbendazim and pyraclostrobin, respectively.
Multiple CSP and mating types were found in TR46/Y121F/T289A (CSP t01, t02 and
t09), TR34/L98H isolates (CSP t02, t04A, t04B and t11) and TR34/L98H/S297T/F495I (CSP
t01, t02, t04A and t11).
3.5. Genetic Diversity of Azole-Resistant Aspergillus fumigatus Isolated from the Clinical Setting
and the Wider Environment with a Focus on Tulip Cultivation
In total, 128 Af isolates were analysed using STRAf typing. These originated from air
(n = 5) and arable soils (n = 43) as part of our previous studies, and from tulip field soils
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(n = 13), tulip bulbs (n = 29), tulip peel waste (n = 13), tulip compost (n = 1) and patients
(n = 18) as described here. Six reference strains that were used in both studies were also
included. Most isolates were also further characterised with CSP and mating gene typing
as well as CYP51A sequence analysis (see Table S1 for details). The STRAf profile for tulip
compost isolate TC TEB6B-1 was inconclusive, showing two different product sizes for six
out of the nine loci, indicative of a mixed culture, and was excluded for further analysis.
Among 127 isolates, 99 distinct unique multilocus genotypes (MLGs) were identified, of
which 88 were represented by single isolates (Figure 3).
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Eleven MLGs were detected in multiple strains (clusters A to K), which can be 
regarded as clonal lineages. Cluster I was the largest cluster with ten isolates, all carrying 
TR46/Y121F/T289A, CSP t01 and MAT1-1, and insensitive to both carbendazim and 
pyraclostrobin (Table 2). This cluster included seven strains isolated from tulip bulbs 
originating from the Netherlands and the UK (T3-5, T4-9, T4-10, T5-1, T5-2, T5-5 and T7-
9), two strains from tulip waste heaps (including TP UT4A-1) and reference strain, TR46-
NL, isolated from the environment in the Netherlands and tested previously [17]. Cluster 
C consisted of nine isolates carrying TR34/L98H, CSP t11 and MAT1-1, with no 
insensitivity observed for carbendazim and pyraclostrobin. Eight isolates originated from 
multiple tulip bulb samples obtained in both the Netherlands and the UK (T1-2, T2-1, T3-
3, T3-6, T4-7, T5-3, T6-3 and T10-5) and a soil isolate, SS8-7A, originating from a sugar beet 
field in Belgium in our previous study [17]. Cluster D contained two reference strains 
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garde as clonal lineages. Cluster I was the largest cluster with ten isolates, all car ying
TR46/ T289A, t01 and MAT1-1, and inse sitive to both carbendazim and pyra-
clostrobin (Table 2). This cluster included seven strains isolated from tulip bulbs originating
from the Netherlands and the UK (T3-5, T4-9, T4-10, T5-1, T5-2, T5-5 and 7 9), two strains
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from tulip waste heaps (including TP UT4A-1) and reference strain, TR46-NL, isolated
from the environment in the Netherlands and tested previously [17]. Cluster C consisted of
nine isolates carrying TR34/L98H, CSP t11 and MAT1-1, with no insensitivity observed for
carbendazim and pyraclostrobin. Eight isolates originated from multiple tulip bulb sam-
ples obtained in both the Netherlands and the UK (T1-2, T2-1, T3-3, T3-6, T4-7, T5-3, T6-3
and T10-5) and a soil isolate, SS8-7A, originating from a sugar beet field in Belgium in our
previous study [17]. Cluster D contained two reference strains (TR34-NL and 08-19-02-10,
isolated in the Netherlands in 2008) and arable soil isolate RN8-18, carrying TR34/L98H,
CSP t04B and MAT1-2, all showing sensitivity to carbendazim and pyraclostrobin in our
previous study [17]. Cluster E is formed by two clinical strains, CYP_15_7 and V093-54,
from Belgium and the Netherlands, respectively, and STNL5-C8, a Dutch tulip field soil
isolate, all carrying TR46/Y121F/T289A, CSP t01 and MAT1-2, all showing insensitivity
to both carbendazim and pyraclostrobin. The remaining clusters contained two isolates.
Cluster F contained strain TP UT5C-5, isolated from a tulip peel waste heap sample, and
clinical strain OKH50 isolated in Japan in 2016 [34], both carrying TR34/L98H, CSP t02
and MAT1-2. Both isolates were sensitive to carbendazim, but only TP UT5C-5 was in-
sensitive to pyraclostrobin. Two tulip waste heap isolates, including TP UT1B-1, formed
cluster H, both carrying TR34/L98H, CSP t11 and MAT1-1, and insensitive to carbendazim
and pyraclostrobin. Clusters J and K are formed by F46Y/M172V/E427K isolates with
low levels of insensitivity to azoles detected previously (ref) and carried combinations of
CSP t13 with MAT1-2 and CSP t02B with MAT1-1, respectively. All F46Y/M172V/E427K
isolates grouped together in the upper right branch positioned above cluster J in Figure 3.
With the exception of isolate STNL2-C9, no insensitivity to fungicides other than azoles
have been detected in isolates carrying F46Y/M172V/E427K. The remaining clusters, A, B
and G, were formed by wild-type CYP51A isolates carrying CSP t04A with MAT1-1, CSP
t01 with MAT1-1, and t18A with MAT1-1, respectively, and all showing sensitivity to all
fungicides tested.
4. Discussion
Tulip bulbs have previously been identified as a vehicle for the international spread
of azole resistant Af isolates [23,24], and decaying flower bulb waste from farms has
already been identified as a hotspot in a previous study [25]. However, little is known
about the emergence and spatiotemporal spread of different fungicide resistant alleles
belonging to different modes of action, such as MBC, QoI and SDHI fungicides [17], in
this environment. In this study, we sampled Af populations from tulip field soils, tulip
bulbs, tulip peel waste heaps and tulip grower compost and compared their fungicide
sensitivity status to both azole and non-azole fungicides. A selection of fungicide insensitive
isolates associated with tulip cultivation and a panel of medical isolates were further
characterized for presence of fungicide resistant alleles and genotyped using CSP and
STRAf typing [26,27]. Several clones were identified and the level of clonal expansion
of pan-azole and non-azole resistant strains in both the clinical setting and the wider
environment is also further discussed hereinafter.
The 5.6% frequency (ten out of 180 isolates) of pan-azole insensitive Af strains isolated
from Dutch tulip field soils in 2016 (Table 1) was higher than the reported 0.5% (two
out 428 isolates) measured for arable soils sampled at nine different locations in France,
Germany, and the UK in 2015 using the same sampling and test procedures [17]. Three
out of the ten pan-azole insensitive isolates, all sampled from the same tulip field carried
TR46/Y121F/T289A, while six TR34/L98H and one TR34/L98H/S297T/F495I strain were
identified as well. One TR34/L98H, STNL6-B1, and all three TR46/Y121F/T289A isolates,
STNL5-B7, STNL5-C1 and STNL5-C7, were also insensitive to both the MBC fungicide
carbendazim and the QoI fungicide pyraclostrobin (Table 2) which was attributed to
alterations in β-tubulin (F200Y) and cytochrome b (G143A), respectively, as previously
reported [17]. One of the TR46/Y121F/T289A strains, STNL5-C8, shared a MLG (26-21-9-
33-11-22-8-14-10) with clinical isolates from the Netherlands and environmental isolates
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from India and Tanzania [35,36]. Interestingly, STNL6-B1 was also insensitive to the
SDHI fungicide boscalid and carried the SdhB alteration H270Y, a change associated
with SDHI resistance [17]. The TR34/L98H/S297T/F495I isolate, STNL5-C5, was also
insensitive to carbendazim and showed a double mutation resulting in the F200Y β-tubulin
alteration. One F46Y/M172V/E427K isolate, STNL2-C9, showing low levels of insensitivity
to azoles, was also moderately insensitive to pyraclostrobin (MIC value of 6.017 µg/mL)
and carried cytochrome b F129L, an alteration well known to confer low to moderate levels
of QoI resistance in plant pathogenic fungi [37], and recently also reported for Af [19].
Only one azole sensitive strain, STNL1-A8, carrying wild-type CYP51A appeared to have
evolved carbendazim insensitivity by acquiring the beta-tubulin F200Y allele, which has
been reported once before [19]. Azole resistance seems to have spread quickly after the
emergence of TR34- and TR46-based CYP51A variants, with subsequent selection within
these populations for resistance to fungicides belonging to other modes of actions in
environments where multiple classes of fungicides are present. The presence of an azole
sensitive isolate with carbendazim insensitivity can be explained by the rare emergence and
survival of this strain in an environment with and without MBC fungicides, in the absence
of azole fungicides or before azoles were introduced. Alternatively, this isolate could also
be the offspring from a cross between a multi-fungicide resistant azole insensitive isolate
and a wild-type strain.
High numbers of Af colonies (up to 100 per bulb) were isolated from the tulip bulb
samples when sampling the outer peels, which is in accordance with other studies in-
vestigating tulip and flower bulb samples [23,24]. The frequency of pan-azole resistant
isolates was higher for the population isolated from tulip bulbs with 25 out of 108 isolates
(23.1%) detected in 2015. The frequency was higher for bulbs purchased in the Netherlands
(36.7%, 22 out of 60) than for bulbs purchased in the UK (6.3%, three out of 48), but the
frequency for the UK-produced bulb population could be lower as it is likely that some
purchased bulbs were directly imported from the Netherlands and not cultivated in the
UK. No pan-azole resistant isolates were detected in populations sampled from Dutch
tulip bulbs or UK daffodil bulbs in 2017, although the population size was smaller with
20 and 30 isolates, respectively. Seven out of the 25 pan-azole resistant isolates from the
tulip bulb population carried TR46/Y121F/T289A and were also highly insensitive to both
carbendazim and pyraclostrobin. These seven isolates originated from different tulip bulb
samples purchased in the Netherlands and the UK in 2015 and formed together with two
Dutch tulip peel waste heap strains, isolated in 2018, and a Dutch environmental reference
strain (TR46-NL), isolated before 2014, a cluster (cluster I in Figure 3) with an identical
CSP type (t01), mating type (MAT1-1) and MLG (26-21-12-26-9-20-13.3-9-9), indicative for a
clonal lineage [28]. The same MLG clone has also been widely reported for both clinical
and environmental strains from the Netherlands in the past [35,36], showing its spread
and longevity through asexual reproduction. The successful expansion of this clone can be
explained by a greater fitness in comparison with other genotypes. The presence of both
β-tubulin F200Y and cytochrome b G143A alleles, conferring resistance to MBC and QoI
fungicides, respectively, will increase the chance of survival in environments where multi-
ple modes of fungicides are used (bulb dipping, seed treatments and foliar sprays) or can be
found (plant waste and compost heaps). One pan-azole resistant tulip bulb isolate carrying
TR34/L98H (T11-8) was also insensitive to carbendazim and pyraclostrobin and can also
be considered as a clonal lineage as strains with an identical MLG (14-20-9-31-9-10-8-10-28)
have been reported in clinical and environmental strains from India and in environmental
strains from Tanzania [36,38]. The successful rapid expansion of this clone in India can be
explained by its multi-fungicide resistance status, the ability to outcompete other strains
in the presence of MBC and/or QoI fungicides upon its arrival in India. However, the
emergence of this strain in India through sexual recombination and subsequent spread to
other continents cannot be ruled out [38]. In this context it would be interesting to see if the
clonal expansion of a TR34/L98H strain (MLG 22-10-9-9-9-23-8-10-8) reported in compost
in 13 different cities in Iran can also be explained by the presence of additional fungicide
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resistant alleles in this clone [39]. The remaining 17 pan-azole resistant isolates were all
sensitive to both carbendazim and pyraclostrobin. At least 11 of these carried TR34/L98H,
from which at least eight were grouped together with a 2016 sugar beet field soil isolate
from Belgium in cluster C, having an identical MLG (20-21-16-77-12-11-16.3-11-21), CSP t11
and MAT1-1 in common. As far as we know, this clone has not been reported before.
As expected, the highest frequency of pan-azole resistant isolates, 52.4%, was detected
in samples collected from tulip peel waste heaps with 22 out of 42 isolates detected. The
frequency of pan-azole resistant strains in compost samples could not be determined as Af
isolates were mainly recovered from tebuconazole-amended agar due to excessive growth
of other fungi on agar without addition of tebuconazole. High frequencies of up to 21.5%
for recovery of pan-azole resistant strains from flower bulb waste heaps has also been
reported in earlier studies [25]. Almost all pan-azole resistant strains (21 out of 22) were
also highly insensitive to both carbendazim and pyraclostrobin, non-azole fungicides with
different modes of action that are commonly found in tulip peel or flower waste heaps
because of their application in bulb dipping and/or as part of foliar sprays to control
diseases like Fusarium and Botrytis. Further evaluation of tulip peel waste heap and
compost isolates showed that most multi-fungicide resistant isolates with high levels of
voriconazole insensitivity (MIC value > 19.120 µg/mL) carried TR46/Y121F/T289A, but
a more complex CYP51A variant, TR34/L98H/T289A/I364V/G448S, was also detected
in two isolates that were isolated from colonies growing on tebuconazole-amended agar
(Table 2). This variant has been found in clinical strains from South Korea [40] and the UK
since 2016 [41], but has also been reported in strains isolated from imported Dutch tulip
bulbs in Japan in 2018 [24], and from compost heap samples in the UK in 2019 that were
sampled as part of a citizen-science project [42]. The emergence of more complex variants
over time shows similarities with the evolution of azole resistance in the plant pathogen
Zymoseptoria tritici, where a stepwise accumulation of CYP51 mutations has resulted in
adaptation to higher azole dose rates and/or new azoles with different binding properties
entering the market [43].
The collection of clinical isolates used in this study showed a wide variety of fungicide
sensitivity pheno- and genotypes that were also found in the environmental isolates.
CYP51A variants TR34/L98H, TR34/L98H/S297T/F495I and TR46/Y121F/T289A, were
detected in eight, four, eight and six isolates, respectively. The highest levels of insensitivity
to voriconazole, imazalil and tebuconazole were generally measured for isolates carrying
TR46/Y121F/T289A, while TR34/L98H/S297T/F495I isolates were generally less sensitive
to imazalil than TR34/L98H isolates which can be explained by the presence of F495I, which
particularly affects the binding of imidazoles such as prochloraz and imazalil [12]. Three
out of the four TR34/L98H/S297T/F495I isolates carried beta-tubulin F200Y and were
highly insensitive to the MBC fungicide carbendazim. All six TR46/Y121F/T289A strains
carried both beta-tubulin F200Y and cytochrome b G143A alleles, the latter conferring high
levels of insensitivity to the QoI fungicide pyraclostrobin. One TR46/Y121F/T289A strain,
CYP_15_38 with a rare CSP type t09, was also insensitive to boscalid, a SDHI fungicide, and
carried SdhB H270Y. Two out of eight TR34/L98H isolates, ARAF017 and CYP_51_46, were
also insensitive to all three non-azole fungicides carbendazim, pyraclostrobin and boscalid.
One new fungicide resistant allele was detected, beta-tubulin E198A in isolate CYP_51_46,
conferring resistance to carbendazim. This allele, like beta-tubulin F200Y, commonly found
in plant pathogens that developed resistance to MBC fungicides [44], has recently been
reported in Af [17].
STRAf typing of the clinical isolates revealed three additional clonal lineages. The
German clinical isolate Asp 261, carrying TR34/L98H/S297T/F495I and beta-tubulin F200Y,
shared an identical MLG (14-10-9-30-9-6-8-10-20) with clinical strain Afu_key29 reported
in Denmark [12]. Two clinical TR46/Y121F/T289A isolates, V093-54 and CYP_15_7 from
the Netherlands and Belgium, respectively, shared the same MLG (26-21-9-33-11-22-8-
14-10), CSP type (t01) and mating type (MAT1-2) with the Dutch tulip field soil isolate
STNL5-C8 and all three isolates carried beta-tubulin F200Y and cytochrome b G143A alleles.
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Finally, tulip peel waste heap isolate TP UT5C-5 and clinical isolate OKH50, isolated in
Japan in 2016, shared the same MLG (14-21-8-31-9-6-8-10-20) (cluster F in Figure 3) with
an Irish clinical strain D5 isolated in 2015 [23], all carrying TR34/L98H. Traits like CSP
t02 and MAT1-2 were shared between TP UT5C-5 and OKH50, but only TP UT5C-5 was
highly insensitive to pyraclostrobin. This shows that pan-azole resistant clones of Af
can spread and develop de novo resistant alleles under exposure to different fungicides
in hotspots. Using MLGs only based on STRAf typing might underestimate the spread
of clones as low levels of instability have recently been reported for markers 3A and
3C. The recently reported MLG (14-21-8-32-9-6-8-10-20) for Chinese farm soil isolates
carrying TR34/L98H could also represent descendants of the same clone as OKH50 [45].
Whole genome sequencing and/or further typing using additional markers targeting
hypervariable TRs within exons of surface protein coding genes will be needed to confirm
this [41,46].
5. Conclusions
The understanding of the emergence and epidemics of pan-azole resistant Af over
time has been improved by this and other recently published research linking strains found
in patients with genotypes distributed in the wider environment [41,47]. The acquisition
of azole-resistant alleles in clinical and/or environmental settings, as well as non-azole
fungicide resistant alleles in the environment, have contributed to the rapid expansion of
clonal lineages in hotspots under selection by fungicides, where sexual reproduction can
also generate new genotypes with combinations of fungicide resistant alleles. Continuous
real-time surveillance of aerosol samples at different locations for the presence of Af
combined with identification of CYP51A variants and other fungicide resistant alleles using
a NGS genomics approach can provide information on the emergence and spatiotemporal
dynamics of newly evolved strains. The detection of newly evolved azole resistant strains
and clones can also be used to identify hotspots, where measures can be devised to reduce
reproduction and/or fungicide selection pressure, aiming to minimize the risk of human
exposure to airborne pan-azole resistant Af conidia through inhalation. Strains carrying
novel CYP51A variants, based on new mutations and or combinations of (new) mutations,
as well as strains harboring different azole resistance mechanisms [48], should be tested
against all available azole antifungals, as changes in their azole susceptibility status can
guide decisions for an optimal diagnosis and management of aspergillosis in patients [49].
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